India Globalization Capital Shares Move Higher; Co Says Phase 1 Clinical Trial Provides Insights On Safe, Effective Dosing Of IGC-AD1 For Alzheimer's Patients
India Globalization Capital Shares Move Higher; Co Says Phase 1 Clinical Trial Provides Insights On Safe, Effective Dosing Of IGC-AD1 For Alzheimer's Patients | Quantisnow